Meta-analysis of dyspepsia and nonsteroidal antiinflammatory drugs.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Arthritis & Rheumatism

• Publication date

  2003-08-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ART.11192PMID 12910557
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A double-blind multicentre trial of piroxicam and naproxen in osteoarthritis

  2005cited by this paper
• Aceclofenac is a well-tolerated alternative to naproxen in the treatment of osteoarthritis

  2005cited by this paper
• Comparison of faecal blood loss, upper gastrointestinal mucosal integrity and symptoms after piroxicam beta-cyclodextrin, piroxicam and placebo administration

  2004cited by this paper
• A comparison of the efficacy of etodolac SR (Lodine® SR) and etodolac (Lodine®) in patients with rheumatoid arthritis or osteoarthritis

  2004cited by this paper
• Gastrointestinal tolerability of the selective cyclooxygenase-2 (COX-2) inhibitor rofecoxib compared with nonselective COX-1 and COX-2 inhibitors in osteoarthritis.

  2000cited by this paper
• Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.

  2000cited by this paper
• Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial.

  1999cited by this paper
• AGA technical review: Evaluation of dyspepsia ☆ ☆☆

  1998cited by this paper
• AGA technical review: evaluation of dyspepsia. American Gastroenterological Association.

  1998cited by this paper
• Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

  1998cited by this paper
• Efficacy and safety of meloxicam in patients with rheumatoid arthritis.

  1997cited by this paper
• [Efficacy and safety of nabumetone in the treatment of knee osteoarthritis: a comparative clinical trial versus aceclofenac. Study Group of Nabumetone for Osteoarthritis of the Knee].

  1997cited by this paper
• Nonsteroidal Antiinflammatory Drugs, Ulcers and Risk: A Collaborative Meta-Analysis

  1997cited by this paper
• Double blind evaluation of the long-term effects of etodolac versus ibuprofen in patients with rheumatoid arthritis.

  1997cited by this paper
• Comparison of aceclofenac with piroxicam in the treatment of osteoarthritis

  1997cited by this paper
• [Efficacy and safety of nabumetone in the treatment of knee osteoarthritis: a comparative clinical trial versus aceclofenac. Study Group of Nabumetone for Osteoarthritis of the Knee].

  1997cited by this paper
• Efficacy and Tolerability of Meloxicam versus Piroxicam in Patients with Osteoarthritis of the Hip or Knee

  1997cited by this paper
• Double blind evaluation of the long-term effects of etodolac versus ibuprofen in patients with rheumatoid arthritis.

  1997cited by this paper
• Nonsteroidal antiinflammatory drugs, ulcers and risk: a collaborative meta-analysis.

  1997cited by this paper
• Comparison of the efficacy and safety of etodolac and piroxicam in patients with rheumatoid arthritis. Etodolac Study 326 Rheumatoid Arthritis Investigators Group.

  1997cited by this paper
• Assessing the quality of reports of randomized clinical trials: is blinding necessary?

  1996cited by this paper
• Aceclofenac is as safe and effective as tenoxicam in the treatment of ankylosing spondylitis: a 3 month multicenter comparative trial. Spanish Study Group on Aceclofenac in Ankylosing Spondylitis.

  1996cited by this paper
• The efficacy and tolerability of an 8-day administration of intravenous and oral meloxicam: A comparison with intramuscular and oral diclofenac in patients with acute lumbago

  1996cited by this paper
• A six-month double-blind trial to compare the efficacy and safety of meloxicam 7.5 mg daily and naproxen 750 mg daily in patients with rheumatoid arthritis.

  1996cited by this paper
• Excess costs from gastrointestinal disease associated with nonsteroidal anti-inflammatory drugs

  1996cited by this paper
• The efficacy and tolerability of aceclofenac in the treatment of patients with ankylosing spondylitis: a multicenter controlled clinical trial. Aceclofenac Indomethacin Study Group.

  1996cited by this paper
• Aceclofenac is as safe and effective as tenoxicam in the treatment of ankylosing spondylitis: a 3 month multicenter comparative trial. Spanish Study Group on Aceclofenac in Ankylosing Spondylitis.

  1996cited by this paper
• A double-blind study to compare the efficacy and safety of meloxicam 15 mg with piroxicam 20 mg in patients with osteoarthritis of the hip.

  1996cited by this paper
• A multicenter, randomized, double blind study comparing lornoxicam with diclofenac in osteoarthritis.

  1996cited by this paper
• Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis

  1996cited by this paper
• The risks and costs of upper gastrointestinal disease attributable to NSAIDs.

  1996cited by this paper
• A post-marketing surveillance study of Voltarol 75 mg SR in the primary care setting.

  1996cited by this paper
• Tenidap in patients with rheumatoid arthritis. A 4-week, placebo-controlled study.

  1996cited by this paper
• The efficacy and tolerability of an 8-day administration of intravenous and oral meloxicam: a comparison with intramuscular and oral diclofenac in patients with acute lumbago. German Meloxicam Ampoule Study Group.

  1996cited by this paper
• Early or Deferred Zidovudine Therapy in HIV-Infected Patients without an AIDS-Defining Illness

  1995cited by this paper
• Impact of Preexisting Health Conditions on the Outcome of an Adverse Drug Reaction Alerting Program: Gastrointestinal Disorders Before Piroxicam and Sulindac Therapy

  1995cited by this paper
• Gastroduodenal tolerability of nabumetone versus naproxen in the treatment of rheumatic patients.

  1995cited by this paper
• A multicenter study of nabumetone and diclofenac SR in patients with osteoarthritis.

  1995cited by this paper
• Comparison of the efficacy and safety of oxaprozin and nabumetone in the treatment of patients with osteoarthritis of the knee.

  1995cited by this paper
• Peptic ulcer and gastrointestinal hemorrhage associated with nonsteroidal anti-inflammatory drug use in patients younger than 65 years. A large health maintenance organization cohort study.

  1995cited by this paper
• A Double-Blind Study Comparing Nimesulide with Naproxen in the Treatment of Osteoarthritis of the Hip

  1995cited by this paper
• Double-blind, placebo-controlled comparison of the safety and efficacy of orally administered etodolac and nabumetone in patients with active osteoarthritis of the knee.

  1995cited by this paper
• Efficacy and safety of etodolac and naproxen in patients with osteoarthritis of the knee: a double-blind, placebo-controlled study.

  1995cited by this paper
• Epidemiology of upper dyspepsia in a random population. Prevalence, incidence, natural history, and risk factors.

  1994cited by this paper
• Double-blind study evaluating by endoscopy the tolerability of nimesulide and diclofenac on the gastric mucosa in osteoarthritic patients.

  1994cited by this paper
• Interrelationships betweenHelicobacter pylori infection, nonsteroidal antiinflammatory drugs and gastroduodenal disease

  1994cited by this paper
• NSAID-induced gastroduodenal damage: is prevention needed? A review and metaanalysis.

  1993cited by this paper
• A controlled study comparing the effects of nabumetone, ibuprofen, and ibuprofen plus misoprostol on the upper gastrointestinal tract mucosa.

  1993cited by this paper
• Safety experience with nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in osteoarthritis and rheumatoid arthritis.

  1993cited by this paper
• Comprehensive geriatric assessment: a meta-analysis of controlled trials.

  1993cited by this paper
• The cost-effectiveness of misoprostol for nonsteroidal antiinflammatory drug-associated adverse gastrointestinal events.

  1993cited by this paper
• Efficacy and safety of nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in the elderly.

  1993cited by this paper
• Double-blind comparison of efficacy and gastroduodenal safety of diclofenac/misoprostol, piroxicam, and naproxen in the treatment of osteoarthritis.

  1993cited by this paper
• No effect of piroxicam on achilles tendinopathy. A randomized study of 70 patients.

  1992cited by this paper
• A double blind, multicentre, placebo controlled trial of lornoxicam in patients with osteoarthritis of the hip and knee.

  1992cited by this paper
• A prospective randomized study of the injurious effects of aspirin and naproxen on the gastroduodenal mucosa in patients with rheumatoid arthritis.

  1992cited by this paper
• Piroxicam spares buprenorphine after total joint replacement. Controlled study of pain treatment in 81 patients.

  1992cited by this paper
• A double‐blind gastroscopic evaluation of the effects of etodolac and naproxen on the gastrointestinal mucosa of rheumatic patients

  1991cited by this paper
• Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons.

  1991cited by this paper
• Double-blind, parallel comparison of etodolac and naproxen in patients with osteoarthritis of the knee

  1991cited by this paper
• Functional dyspepsia : a classification with guidelines for diagnosis and management

  1991cited by this paper
• Nonsteroidal anti-inflammatory drugs and peptic ulcer disease.

  1991cited by this paper
• Double-blind, parallel comparison of etodolac and indomethacin in patients with osteoarthritis of the knee.

  1991cited by this paper
• Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis.

  1991cited by this paper
• Diclofenac delays healing of gastroduodenal mucosal lesions

  1991cited by this paper
• Comparison of salsalate and aspirin on mucosal injury and gastroduodenal mucosal prostaglandins.

  1990cited by this paper
• Some Statistical Methods for Combining Experimental Results

  1990cited by this paper
• Definition and investigation of dyspepsia

  1989cited by this paper
• A safety profile of controlled release naproxen tablets.

  1989cited by this paper
• Definition and investigation of dyspepsia. Consensus of an international ad hoc working party.

  1989cited by this paper
• Dyspepsia in NSAID Users: The Size of the Problem

  1989cited by this paper
• Meta‐analysis of randomized controlled trials as a method of estimating rare complications of non‐steroidal anti‐inflammatory drug therapy

  1988cited by this paper
• Nonsteroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons.

  1988cited by this paper
• Treatment of Acute Low-back Pain with Piroxicam: Results of a Double-blind Placebo-controlled Trial

  1987cited by this paper
• A double blind comparison of diclofenac and indomethacin in the treatment of ankylosing spondylitis.

  1987cited by this paper
• Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal anti-inflammatory drug use.

  1987cited by this paper
• [Therapy of activated arthroses with antirheumatic agents in retard form].

  1986cited by this paper
• Double-blind comparison of flurbiprofen and sulindac for the treatment of osteoarthritis.

  1986cited by this paper
• Piroxicam and naproxen in osteoarthritis. A double-blind, comparative multicentre trial carried out in general practice

  1986cited by this paper
• Single and Multiple Dose Analgesic and Kinetic Studies of Mefenamic Acid in Chronic Back Pain

  1986cited by this paper
• A randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia.

  1986cited by this paper
• Oxaprozin in the treatment of patients with tendinitis and bursitis: Comparison with phenylbutazone and placebo

  1986cited by this paper
• Effect of diclofenac sodium, tolfenamic acid and indomethacin on the production of superoxide induced by N-formyl-methionyl-leucyl-phenylalanine in normal human polymorphonuclear leukocytes.

  1986cited by this paper
• Nonsteroidal antiinflammatory drug therapy in rheumatoid arthritis: A comparison of oxaprozin and ibuprofen

  1986cited by this paper
• A comparison of single daily doses of oxaprozin with multiple daily doses of ibuprofen for the treatment of rheumatoid arthritis

  1986cited by this paper
• [Piroxicam and naproxen in acute soft tissue injuries].

  1986cited by this paper
• Medical treatment of acute low back pain. Diflunisal compared with indomethacin in acute lumbago.

  1986cited by this paper
• A 12-week, double-blind, multicenter study comparing diflunisal twice daily and ibuprofen four times daily in the treatment of rheumatoid arthritis.

  1986cited by this paper
• A Double-Blind Study Comparing Ibuprofen 1800 mg or 2400 mg Daily and Placebo in Sports Injuries

  1986cited by this paper
• Effect of Clinoril (sulindac, MSD), piroxicam and placebo on the hypotensive effect of propranolol in patients with mild to moderate essential hypertension.

  1986cited by this paper
• [Piroxicam and naproxen in arthrosis. A double-blind, comparative multicenter study in general practice].

  1986cited by this paper
• Antiphlogistics in acute inflammatory conditions in the soft tissues of the musculo-skeletal system ― a double blind comparison of diclofenac and indomethacin

  1985cited by this paper
• Effects of ibuprofen on normal subjects: clinical and routine and special laboratory assessments

  1985cited by this paper
• A double-blind multicenter comparison of isoxicam and diclofenac in the treatment of osteoarthritis

  1985cited by this paper
• Piroxicam vs indomethacin: a double blind multicenter comparative study in osteoarthritis. A Canadian Multicenter Study.

  1985cited by this paper
• Successful migraine prophylaxis with naproxen sodium

  1985cited by this paper
• Ro 12-0068 (tenoxicam) in the treatment of extra-articular inflammatory processes.

  1985cited by this paper
• Treatment of ocular inflammation with diclofenac sodium: double-blind trial following cataract surgery.

  1985cited by this paper
• A followup study of ibuprofen users.

  1985cited by this paper
• Treatment of sports injuries with naproxen sodium and dextropropoxyphene napsylate.

  1985cited by this paper

• Factors influencing subjective well-being in individuals with functional dyspepsia — a path analysis of sex and psychological factors

  2026cites this paper
• The use of pain killers (NSAIDs) in athletes: How large is the risk?

  2024cites this paper
• ASSESSMENT OF DIETARY AND LIFESTYLE FACTORS ASSOCIATED WITH DYSPEPSIA: A QUESTIONNAIRE-BASED STUDY

  2024cites this paper
• Impact of OTC Purchase and Utilization of Pain Killers in Rheumatoid Arthritis

  2023cites this paper
• Acute and sub chronic toxicity studies with herbal pain relieving formula (Rhuleave-K™) in rats.

  2022cites this paper
• Non-steroidal anti-inflammatory drugs (NSAIDs) for musculoskeletal pain

  2021cites this paper
• Relative risk of functional dyspepsia in patients with sleep disturbance: a population-based cohort study

  2021cites this paper
• Efficacy of high-dissolution turmeric-sesame formulation for pain relief in adult subjects with acute musculoskeletal pain compared to acetaminophen

  2020cites this paper
• Uses of Proton Pump Inhibitors and Their Prescribing Pattern among the Patients Attending the Out-Patient Department at a Tertiary Care Hospital in Bangladesh

  2020cites this paper
• Prevention, Diagnosis, and Management of Opioids, Opioid Misuse, and Opioid Use Disorder in Older Adults

  2020cites this paper
• Management of functional dyspepsia in the year 2020. A clinical point of view.

  2020cites this paper
• Economic impact of potentially inappropriate prescribing and related adverse events in older people: a cost-utility analysis using Markov models

  2019cites this paper
• A Case Report on Functional Dyspepsia in a Fibromyalgia Patient with a History of Long-Term Nonsteroidal Anti-inflammatory Drugs (NSAIDs) Use

  2019cites this paper
• Purple Willow (Salix purpurea L.) and Its Potential Uses for the Treatment of Arthritis and Rheumatism

  2019cites this paper
• Pathology, Chemoprevention, and Preclinical Models for Target Validation in Barrett Esophagus.

  2018cites this paper
• Dyspepsia in non‐steroidal anti‐inflammatory drug users and the effect of preventive measures

  2018cites this paper
• Efficacy and safety of amtolmetin guacil in the therapy of osteoarthritis and associated dyspepsia in routine clinical practice: agatha

  2018cites this paper
• Practice guidelines for pharmacists: The management of osteoarthritis

  2017cites this paper
• The association between gastro-oesophageal reflux disease and subsequent rheumatoid arthritis occurrence: a nested case–control study from Taiwan

  2017cites this paper
• An open label multicenter observational study of the efficacy , tolerability and safety of Amtolmetin Guacil – a non-steroidal anti-inflammatory drug , in patients with knee osteoarthritis and dyspepsia

  2017cites this paper
• Effects of aspirin and non-aspirin nonsteroidal anti-inflammatory drugs on the incidence of recurrent colorectal adenomas: a systematic review with meta-analysis and trial sequential analysis of randomized clinical trials

  2017cites this paper
• Effects of chemopreventive agents on the incidence of recurrent colorectal adenomas: a systematic review with network meta-analysis of randomized controlled trials

  2017cites this paper
• Management of Gout

  2016cites this paper
• Cost-effectiveness of Low-dose Submicron Diclofenac Compared With Generic Diclofenac.

  2016cites this paper
• Pharmacoepidemiology and economic evaluation of measures of potentially inappropriate prescribing

  2016cites this paper
• Synthesis, Crystal Structure and Spectroscopic Properties of 1,2-Benzothiazine Derivatives: An Experimental and DFT Study

  2015cites this paper
• Approach to the patient with dyspepsia and related functional gastrointestinal complaints

  2015cites this paper
• Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Induced Dyspepsia.

  2015cites this paper
• Anxiety Is Linked to New-Onset Dyspepsia in the Swedish Population: A 10-Year Follow-up Study.

  2015cites this paper
• Risk of Upper Gastrointestinal Ulcers in Patients With Osteoarthritis Receiving Single-Tablet Ibuprofen/Famotidine Versus Ibuprofen Alone: Pooled Efficacy and Safety Analyses of Two Randomized, Double-Blind, Comparison Trials

  2014cites this paper
• Gastrointestinal comorbidities associated with atrial fibrillation

  2014cites this paper
• Gastrointestinal symptoms in NSAID users in an ‘average risk population’: results of a large population‐based study in randomly selected Dutch inhabitants

  2014cites this paper
• Pharmacodynamic evaluation of intragastric pH and implications for famotidine dosing in the prophylaxis of non-steroidal anti-inflammatory drug induced gastropathy—a proof of concept analysis

  2014cites this paper
• Therapeutic Options for Functional Dyspepsia

  2014cites this paper
• Relationship between diclofenac dose and risk of gastrointestinal and cardiovascular events: meta-regression based on two systematic literature reviews.

  2014cites this paper
• Oral herbal therapies for treating osteoarthritis.

  2014cites this paper
• Use of nonsteroidal anti‐inflammatory drugs in the older adult

  2014cites this paper
• Association between adherence to concomitant proton pump inhibitor therapy in current NSAID users and upper gastrointestinal complications

  2013cites this paper
• Gastroprotective strategies in chronic NSAID users: a cost-effectiveness analysis comparing single-tablet formulations with individual components.

  2013cites this paper
• Risk stratification in upper gastrointestinal bleeding; prediction, prevention and prognosis

  2013cites this paper
• Prevalence and determinants of gastrointestinal symptoms in the Dutch community

  2013cites this paper
• Cost-Effectiveness Analyses of Osteoarthritis Oral Therapies: a Systematic Review

  2013cites this paper
• NSAIDs in the older patient: balancing benefits and harms.

  2013cites this paper
• Evidence-Based Approach to Dyspepsia: From Helicobacter pylori to Functional Disease

  2013cites this paper
• Esomeprazole relieves upper gastrointestinal symptoms in high-risk and average-risk NSAID users in daily clinical practice: results from an open-label study

  2012cites this paper
• Dyspepsia prevalence in general population aged over 20 in the west part of Iran.

  2012cites this paper
• Dyspepsia: Organic Versus Functional

  2012cites this paper
• Unmet Needs in Non-steroidal Anti-inflammatory Drug-induced Upper Gastrointestinal Diseases

  2012influential citation
• Systematic review of methods used in meta-analyses where a primary outcome is an adverse or unintended event

  2012cites this paper
• Managing Headache in Older People

  2011cites this paper
• Persistence with non-selective NSAIDs and celecoxib among patients with gastroesophageal reflux disease and osteoarthritis or rheumatoid arthritis

  2011cites this paper
• Prevalence and Risk Factors of Gastrointestinal Disorders in Patients with Rheumatoid Arthritis: Results from a Population-Based Survey in Olmsted County, Minnesota

  2011cites this paper
• Upper gastrointestinal symptoms in patients treated with nonsteroidal anti-inflammatory drugs: prevalence and impact – the COMPLAINS study

  2010cites this paper
• A multicentric, randomized, comparative clinical trial to evaluate the efficacy and safety of S-etodolac in the treatment of osteoarthritis in Indian patients.

  2010cites this paper
• Dyspepsia as an adverse effect of drugs.

  2010cites this paper
• Cost‐utility analysis of proton pump inhibitors and other gastro‐protective agents for prevention of gastrointestinal complications in elderly patients taking nonselective nonsteroidal anti‐inflammatory agents

  2010cites this paper
• Review: Evaluation and management of dyspepsia

  2010cites this paper
• Long-term Continuous Subcutaneous Infusion of Ketoprofen Combined With Morphine: A Safe and Effective Approach to Cancer Pain

  2010cites this paper
• Identification of NSAID Users at Risk for Gastrointestinal Complications

  2010cites this paper
• Myths and facts in the use of anti-inflammatory drugs

  2009cites this paper
• Pharmacological management of persistent pain in older persons.

  2009cites this paper
• Pharmacological Management of Persistent Pain in Older Persons

  2009cites this paper
• Evidence of effectiveness of herbal medicinal products in the treatment of arthritis

  2009cites this paper
• Evidence of Effectiveness of Herbal Medicinal Products in the Treatment of Arthritis

  2009cites this paper
• Nonsteroidal anti‐inflammatory drug use as a risk factor for gastro‐oesophageal reflux disease: an observational study

  2008cites this paper
• Chronic gastrointestinal symptoms and quality of life in the Korean population.

  2008cites this paper
• [Management of osteoarthritis].

  2008cites this paper
• Effects of Cytochrome P450 Enzyme Inhibitors on the Pharmacokinetics of Nonsteroidal Anti-inflammatory Drugs and Venlafaxine

  2008cites this paper
• EFFECTS OF CYTOCHROME P450 ENZYME INHIBITORS ON THE PHARMACOKINETICS OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS AND VENLAFAXINE

  2008cites this paper
• Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation.

  2008cites this paper
• Dyspepsia in general practice: incidence, risk factors, comorbidity and mortality.

  2007cites this paper
• Approach to managing musculoskeletal pain: acetaminophen, cyclooxygenase-2 inhibitors, or traditional NSAIDs?

  2007cites this paper
• Ibuprofen and gastrointestinal safety: a dose-duration-dependent phenomenon.

  2007cites this paper
• Systematic review of trials of the effect of continued use of oral non-selective NSAIDs on blood pressure and hypertension*

  2007cites this paper
• Esomeprazole: prevention and treatment of NSAID-induced symptoms and ulcers

  2007cites this paper
• Use of Aspirin and NSAIDs to Prevent Colorectal Cancer

  2007cites this paper
• Nonsteroidal Anti-inflammatory Drugs and Cyclooxygenase-2 Inhibitors for Primary Prevention of Colorectal Cancer: A Systematic Review Prepared for the U.S. Preventive Services Task Force

  2007cites this paper
• Adherence to gastroprotection and the risk of NSAID‐related upper gastrointestinal ulcers and haemorrhage

  2007cites this paper
• Evaluation and management of dyspepsia - current perspectives.

  2007cites this paper
• Comparing Rates of Dyspepsia with Coxibs vs NSAIDPPI

  2006cites this paper
• Comparing rates of dyspepsia with Coxibs vs NSAID+PPI: a meta-analysis.

  2006cites this paper
• COMPASS Therapeutic Notes on the Medical Management of Uninvestigated Dyspepsia in Primary Care

  2006cites this paper
• COMPASS Therapeutic Notes on the Medical Management of Uninvestigated Dyspepsia in Primary Care

  2006cites this paper
• merican Gastroenterological Association Technical Review on he Evaluation of Dyspepsia his literature review and the recommendations

  2005cites this paper
• Meta‐analysis: upper gastrointestinal tolerability of valdecoxib, a cyclooxygenase‐2‐specific inhibitor, compared with nonspecific nonsteroidal anti‐inflammatory drugs among patients with osteoarthritis and rheumatoid arthritis

  2005cites this paper
• The murky world of the COX-2-selective agents

  2005cites this paper
• Gastrointestinal effects of selective and non-selective non-steroidal anti-inflammatory drugs.

  2005cites this paper
• American gastroenterological association technical review on the evaluation of dyspepsia.

  2005cites this paper
• Management of nonsteroidal, anti-inflammatory, drug-associated dyspepsia.

  2005cites this paper
• Should We Eradicate Helicobacter pylori Before Prescribing an NSAID? Result of a Placebo-Controlled Study

  2005cites this paper
• Evidence-based recommendations for short- and long-term management of uninvestigated dyspepsia in primary care: an update of the Canadian Dyspepsia Working Group (CanDys) clinical management tool.

  2005cites this paper
• What the physician needs to know for correct management of gastro‐oesophageal reflux disease and dyspepsia

  2004cites this paper
• Minimizing complications from nonsteroidal anti-inflammatory drugs: the cost-effectiveness of competing strategies in varying risk groups

  2003cites this paper
• DYSPEPSIA AND PREVALENCE OF CLINICALLY SIGNIFICANT ENDOSCOPY FINDINGS IN A GASTROENTEROLOGY REFERRAL CLINIC IN ETHIOPIA

  year unknowncites this paper